Molex (Nasdaq: MOLX ) is expected to report Q2 earnings on Jan. 23. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Molex's revenues will grow 10.7% and EPS will decrease 0.0%.
The average estimate for revenue is $949.6 million. On the bottom line, the average EPS estimate is $0.38.
Last quarter, Molex logged revenue of $916.9 million. GAAP reported sales were 2.0% lower than the prior-year quarter's $936.0 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, EPS came in at $0.40. GAAP EPS of $0.40 for Q1 were 13% lower than the prior-year quarter's $0.46 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 29.3%, 200 basis points worse than the prior-year quarter. Operating margin was 10.4%, 280 basis points worse than the prior-year quarter. Net margin was 7.8%, 80 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $3.79 billion. The average EPS estimate is $1.60.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 134 members out of 149 rating the stock outperform, and 15 members rating it underperform. Among 48 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 45 give Molex a green thumbs-up, and three give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Molex is hold, with an average price target of $26.88.
Looking for alternatives to Molex? It takes more than great companies to build a fortune for the future. Learn the basic financial habits of millionaires next door and get focused stock ideas in our free report, "3 Stocks That Will Help You Retire Rich." Click here for instant access to this free report.